BC
ZBH icon

Bridgefront Capital’s Zimmer Biomet ZBH Stock Holding History

Bridgefront Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,064
Closed -$218K – 883
2024
Q4 		$218K Buy
+2,064
New +$221K 0.07% 466
2024
Q3 		– Sell
-4,161
Closed -$452K – 745
2024
Q2 		$452K Buy
+4,161
New +$491K 0.19% 183
2023
Q1 		– Sell
-1,840
Closed -$235K – 613
2022
Q4 		$235K Sell
1,840
-3,128
-63% -$363K 0.16% 265
2022
Q3 		$519K Buy
+4,968
New +$545K 0.53% 41
2022
Q1 		– Sell
-4,330
Closed -$534K – 441
2021
Q4 		$534K Buy
+4,330
New +$567K 0.52% 46
2021
Q1 		– Sell
-4,282
Closed -$641K – 949
2020
Q4 		$641K Buy
+4,282
New +$605K 0.22% 142

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgefront Capital's ZBH Position: Q1 2025 in Review

Bridgefront Capital sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,064 shares — an estimated $218K sold.

Bridgefront Capital first reported a position in ZBH in Q4 2020 and held it in 6 quarters. The position peaked at $641K in Q4 2020. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Bridgefront Capital reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Bridgefront Capital sold 2,064 Zimmer Biomet shares in Q1 2025, an estimated $218K.
  • Bridgefront Capital first reported a position in Zimmer Biomet in Q4 2020 and held it in 6 quarters.
  • Bridgefront Capital's Zimmer Biomet position peaked at $641K in Q4 2020.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.